Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Orlando, Florida 32809


Purpose:

The purpose of this study is to evaluate the safety and compare the pharmacokinetic parameters from the fixed dose combination ABT-143 relative to that from the co-administration of the two monotherapies.


Criteria:

Inclusion Criteria: 1. A condition of general good health 2. BMI 19 to 29 Exclusion Criteria: 1. Currently enrolled in another clinical study 2. Females who are pregnant or breast-feeding


NCT ID:

NCT00808678


Primary Contact:

Study Director
Torbjörn Lundström, MD
AstraZeneca


Backup Contact:

N/A


Location Contact:

Orlando, Florida 32809
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.